Lactulose

CAS No. 4618-18-2

Lactulose( Lactulose | Cholac | Generlac | Consulose | BRN 0093773 | BRN-0093773 | BRN0093773 )

Catalog No. M14557 CAS No. 4618-18-2

Lactulose is a non-absortable sugar used in the treatment of constipation and hepatic encephalopathy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 29 In Stock

Biological Information

  • Product Name
    Lactulose
  • Note
    Research use only, not for human use.
  • Brief Description
    Lactulose is a non-absortable sugar used in the treatment of constipation and hepatic encephalopathy.
  • Description
    Lactulose is a non-absortable sugar used in the treatment of constipation and hepatic encephalopathy. It generally begin working after eight to twelve hours but may take up to two days to improve constipation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lactulose | Cholac | Generlac | Consulose | BRN 0093773 | BRN-0093773 | BRN0093773
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    β-gal
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    4618-18-2
  • Formula Weight
    342.3
  • Molecular Formula
    C12H22O11
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 68 mg/mL (198.65 mM); DMSO: 68 mg/mL (198.65 mM)
  • SMILES
    OCC1([C@H]([C@@H]([C@@H](CO)O1)O[C@H]2[C@@H]([C@H]([C@H]([C@@H](CO)O2)O)O)O)O)O
  • Chemical Name
    (2S,3R,4S,5R,6R)-2-(((2R,3S,4S)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Algieri F, et al. J Agric Food Chem. 2014 May 14; 62(19):4285-97.
molnova catalog
related products
  • RCM-1

    RCM-1 is an inhibitor of FOXM1. RCM-1 inhibits cellular proliferation via the increasing duration of cell cycle and mitosis in human and mouse cancer cell lines in vitro. RCM-1 inhibits colony formation of cancer cells in vitro in a dose-dependent manner. RCM-1 inhibits the migration of cancer cells in vitro in a dose-dependent manner.

  • Hellebrigenin

    Hellebrigenin has anti-hepatoma activities, it induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.

  • SAH

    SAH is an inhibitor for the METTL3-METTL14 heterodimer complex (METTL3-14 IC50: 0.9 μM).